Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REL-0609: High-Dose vs Standard Clopidogrel in MI Patients
NCT01636180Phase 4Withdrawn
- Sponsor
- Fundacja Ośrodek Badań Medycznych
- Start
- Mar 2012
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in myocardial infarction (MI) comparing Clopidogrel - Repeated Loading Dose with Clopidogrel - standard of care (2 arms). Primary endpoint: Inhibition of platelet aggregation at 30 days. Planned start Mar 2012; status: withdrawn.
02
Drugs
clopidogrel
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT01636180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01636180.